anti-Squamous Cell Carcinoma Antigen 1 (SCCA1) Anticorps

May act as a protease inhibitor to modulate the host immune response against tumor cells.. De plus, nous expédions Squamous Cell Carcinoma Antigen 1 Kits (12) et Squamous Cell Carcinoma Antigen 1 Protéines (3) et beaucoup plus de produits pour cette protéine.

afficher tous les anticorps Gène GeneID UniProt
SCCA1 6317 P29508
Comment commander chez anticorps-enligne
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Commandez enligne
  • orders@anticorps-enligne.fr

Top anti-Squamous Cell Carcinoma Antigen 1 Anticorps sur anticorps-enligne.fr

Showing 6 out of 6 products:

Catalogue No. Reactivité Hôte Conjugué Application Images Quantité Livraison Prix Détails
Humain Lapin Inconjugué ICC, IHC, WB Figure. Western Blot; Sample: Mouse Heart Tissue. 100 μg 13 to 16 Days
$332.00
Détails
Humain Lapin Inconjugué ICC, IHC (fro), IHC (p), ELISA, WB Used in DAB staining on fromalin fixed paraffin-embedded Liver tissue 100 μg 15 to 18 Days
$332.00
Détails
Humain Lapin Inconjugué IF/ICC, IHC, IP, WB Western blot analysis of Mouse Heart Tissue. Western blot analysis of recombinant Human SCCA1. 100 μg 11 to 18 Days
$426.40
Détails
Humain Lapin Inconjugué WB Western blot analysis of SCCA1 expression in Hela (A) 100 μL 11 to 18 Days
$383.76
Détails
Humain Lapin Inconjugué IF/ICC, IHC, IP, WB   100 μg 11 to 18 Days
$426.40
Détails
Humain Souris Inconjugué IF/ICC, IHC, IP, WB   100 μg 11 to 18 Days
$341.12
Détails

Plus d’anticorps contre Squamous Cell Carcinoma Antigen 1 partenaires d’interaction

Human Squamous Cell Carcinoma Antigen 1 (SCCA1) interaction partners

  1. this study shows that SERPINB4 contributes to survival of allergenic TH2 cells

  2. SCCA2 is a reliable biomarker.

  3. Fifty-two of 96 cases (54%) showed evaluated serum SCC antigen levels above the upper limit. The serum SCCA2 level was significantly higher in the head and neck SCC patients than in control group, whereas there were no significant differences in the serum SCCA1 level between head and neck SCC patients and control group.

  4. Results provide evidence that SCCA1 overexpression is associated with poor prognosis in esophageal cancer patients. which is due to reduced tumor chemosensitivity as well as intratumoral immunity impairment, possibly mediated by the induction of the PD-L1 immune checkpoint regulator.

  5. Concurrent elevation of preoperative SCC-Ag, CYFRA 21-1 and CRP serum levels can be correlated with worse survival rates in oral cavity squamous cell carcinoma.

  6. While novel diagnostic tumour markers are urgently needed, the examined potential tumour markers, with the exception of PIVKAII seem to be inadequate for diagnosing HCC in ALC

  7. Results provide the first evidence that failure of serum SCCA to fall into the normal range by the fourth week of definitive radiotherapy is associated with significantly increased risk of recurrence and death.

  8. The combination of SCCA-IgM with common clinical data shows promising diagnostic performance for the detection of Non-alcoholic steato-hepatitis in hepatitis C virus patients

  9. Both periostin and SCCA may play a role in the pathogenesis of acute bronchitis due to respiratory syncytial virus

  10. iron overload and was previously found capable of up-regulating SerpinB3 at the transcriptional level.

  11. the SCCA-IgM determination could be helpful in predicting the response to therapy in patients with hepatocellular carcinoma.

  12. Serum SCC-Ag, hs-CRP, and CA-125 were higher in recurrence cervical patients which could be potential biomarkers for predicting cervical cancer recurrence risk.

  13. A close connection between SerpinB3 and DPPPIV has been identified, but further studies are required to better understand the mechanism by which these proteins communicate and exert metabolic effects in hepatocellular carcinoma.

  14. Findings point to potential interest of squamous cell carcinoma antigen SERPINB3/B4 for the stratification of head and neck squamous cell carcinoma (HNSCC) patients in the therapeutic context.

  15. Serum SCCA2 levels reflected disease severity and clinical type of atopic dermatitis. Serum SCCA2 may thus be a relevant biomarker for atopic dermatitis.

  16. role of SERPINB3/B4 mutations in immunotherapy response

  17. Data show that in colorectal cancer SerpinB3, COX-2 and beta-Catenin are positively correlated and associated with more advanced tumor stage.

Squamous Cell Carcinoma Antigen 1 (SCCA1) profil antigène

Profil protéine

May act as a protease inhibitor to modulate the host immune response against tumor cells.

Gene names and symbols associated with SCCA1

  • serpin family B member 3 (SERPINB3) anticorps
  • serpin family B member 4 (SERPINB4) anticorps
  • HsT1196 anticorps
  • LEUPIN anticorps
  • PI11 anticorps
  • SCC anticorps
  • SCCA-1 anticorps
  • SCCA-2 anticorps
  • SCCA-PD anticorps
  • SCCA1 anticorps
  • SCCA2 anticorps
  • T4-A anticorps

Protein level used designations for SCCA1

protein T4-A , serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 3 , serpin B3 , squamous cell carcinoma antigen 1 , PI-11 , SCCA2/SCCA1 fusion protein , peptidase inhibitor 11 , protease inhibitor (leucine-serpin) , serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 4 , serpin B4 , squamous cell carcinoma antigen 2

GENE ID SPECIES
6317 Homo sapiens
6318 Homo sapiens
Fournisseurs de qualité sélectionnés pour anti-Squamous Cell Carcinoma Antigen 1 (SCCA1) Anticorps
Avez-vous cherché autre chose?